Publications

81. Dhand, R., Dolovich, M., Chipps, B., Myers, T., Restrepo, R., and Farrar.,
J. The role of nebulized therapy in the management of COPD: Evidence
and recommendations. COPD: Journal of Chronic Obstructive Pulmonary
Disease. 2011 (In Press).

80. Zeiger, R., Yegin, F., Simons, T., Haselkorn, T., Rasouliyan, S., Szefler,
S., and Chipps, B. Evaluation of the NHLBI guidelines impairment domain
for the classifying asthma control and predicting asthma exacerbations.
Ann Allergy Asthma Immunol. 2011;108(2):81-87.e3.

82. Chipps, B., Yegin, A., Borish, L., Wenzel, S., Weiss, S., Hayden, M.,
Miller, D., Bleecker, E., Simons, F., Szefler, S., Haselkorn, T. Lessons
learned from the epidemiology and natural history of asthma: Outcomes
and treatment regimens (TENOR) study. J Allergy Clin Immunol. 2011 (In
Press).

86. Sicherer, S., Wood, R., and the SECTION ON ALLERGY AND
IMMUNOLOGY. Allergy Testing in Childhood: Using Allergen-Specific IgE
Tests. Pediatrics. 2012;129(1):193-197.

85. Dhand, R., Dolovich, M., Chipps, B., Myers, T.R., Restrepo, R., Ferrar,
J.R. The role of nebulized therapy in the management of COPD: Evidence
and recommendations. Journal of Chronic Obstructive Pulmonary
Disease. 2012;9:58-72.

84. Zeiger, R., Yegin, A., Simons, E.R., Haselkorn, T., Rasouliyan, L.,
Szefler, S., Chipps, B.E., and the TENOR study group. Evaluation of the
National Heart, Lung, and Blood Institute guidelines impairment domain
for classifying asthma control and predicting asthma exacerbations. Ann
Allergy Asthma Immunol. 2012;108:81-87.